N/A
N=12
Medtronic MiniMed Implantable Insulin Pump
Type 1 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT00298740 ↗Enrolled (actual)
12
Serious AEs
8.3%
Results posted
Sep 2017
Primary outcome: Primary: Glucose Control as Assessed by Mean Glucose Levels
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Aventis U-400 Insulin (Device)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Johns Hopkins University
- Primary completion
- Sep 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Glucose Control as Assessed by Mean Glucose Levels |
— | — |
Summary
This research is being done to find out whether subjects previously treated with the implantable insulin pump (IIP) therapy, and now taking insulin by injection, will benefit from re-implantation of IIP. The investigators will see if IIP causes more stable control of blood sugar, with fewer highs and lows. People with type 1 diabetes previously implanted with the MiniMed Implantable Pump (MIP) model 2000 at Johns Hopkins may join this study.
Eligibility Criteria
Inclusion Criteria
- People with type 1 diabetes previously implanted with the MiniMed Implantable Pump model 2000 at Johns Hopkins may join this study.
Exclusion Criteria
- Anyone not previously implanted with the MiniMed Implantable Pump model 2000 at Johns Hopkins.
Data sourced from ClinicalTrials.gov (NCT00298740). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.